
Alert: New Earnings Report (3/5/25)-EyePoint Pharmaceuticals Inc (NASDAQ: EYPT).
For its fourth fiscal quarter (ending December 31), EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported a 94% increase in E.P.S. from $-0.33 a year ago to $-0.64 in the current quarter. E.P.S. were $-2.32 for […]